CDER Review Manager Search Continues: Acting Head Jolson Departs Agency
Executive Summary
The search for a new acting Office of Review Management Director has begun as acting ORM Director Heidi Jolson, MD, prepares to leave the agency Jan. 26.
You may also be interested in...
Rx Review Management Office Acting Head Is ODE IV Deputy Kweder
Acting Office of Review Management Director Sandra Kweder, MD, is the fourth person to fill the top FDA drug review position in the past six months.
Rx Review Management Office Acting Head Is ODE IV Deputy Kweder
Acting Office of Review Management Director Sandra Kweder, MD, is the fourth person to fill the top FDA drug review position in the past six months.
HIV Trial Modified Factorial Design Best For Study In Treated Patients - Cmte.
Modified factorial trial designs are the best strategy for studying new therapies in heavily treated HIV patients, FDA's Antiviral Drugs Advisory Committee suggested.